MPC1L
ENSG00000238205
Chromosome
X
- Chemical probe available
- No
- Other names
- SLC54A3
- Target name
- MPC1L
- Gene name
- Mitochondrial pyruvate carrier 1 like
- Gene symbol
- MPC1L
- Protein name
- Mitochondrial pyruvate carrier 1-like protein
- Gene biotype
- Protein coding
- Gene family
- Solute carrier family 54, mitochondrial pyruvate carriers
- Target type
- Human gene
- Tissues expressed in
- 1
- Highest tissue expression
- 35.37
- Tissue specificity (Gini)
- 0.981
- Tissue specificity (tau)
- 1
- KEGG gene identifiers
- hsa:347411
- Reactome pathways
- R-HSA-70268
- Protein interaction confidence
- 0.884
- Protein interaction partners
- 1
- End position
- 40624136
- Start position
- 40623428
- Chromosome
- X
- Strand
- Forward
- Mitochondrion inner membrane
- Multi-pass membrane protein .
Publication evidence
- PubMed 27317664
- Tissue specificity (tau)
- 0.999952
- Expression inequality (Gini)
- 0.981387
Expression in transcripts per million
- Testis
- 35.37
- Brain - Cerebellar Hemisphere
- 0.09
- Adipose - Subcutaneous
- 0
- Prostate
- 0
- Brain - Cerebellum
- 0
Expression in transcripts per million
- Testis35.37
- Brain - Cerebellar Hemisphere0.09
- Adipose - Subcutaneous0
- Prostate0
- Brain - Cerebellum0
- Muscle - Skeletal0
- Kidney - Medulla0
- Fallopian Tube0
- Colon - Transverse0
- Lung0
- Brain - Cortex0
- Heart - Atrial Appendage0
- Cells - EBV-transformed lymphocytes0
- Nerve - Tibial0
- Brain - Hippocampus0
- Brain - Putamen (basal ganglia)0
- Ovary0
- Cells - Cultured fibroblasts0
- Brain - Frontal Cortex (BA9)0
- Artery - Aorta0
- Liver0
- Artery - Tibial0
- Bladder0
- Brain - Nucleus accumbens (basal ganglia)0
- Thyroid0
And 29 more, listed on the interactive page.
Biological processes
- GO:0006850
Cellular components
- GO:0005743
Molecular functions
- GO:0005515
Related records
Trials (109)
- [18F]F-DOPA Imaging in Patients With Autonomic Failure
- 3-month Study of MSDC-0160 Effects on Brain Glucose Utilization, Cognition & Safety in Subjects With Alzheimer's Disease
- A Pilot Comparison of Short-course Nitrofurantoin in Females With Uncomplicated Bacterial Cystitis in the Emergency Department
- A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator
- A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])
- A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients
- A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients
- A Study of MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH
- A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
- A Study to Evaluate the Safety, Tolerability & Efficacy of MSDC-0602K in Patients With NASH
- A Study to Investigate the Efficacy and Safety With Gepotidacin in Japanese Female Participants With Uncomplicated Urinary Tract Infection (Acute Cystitis)
- An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States
- An Open Clinical Trial of the Safety and Efficacy of the Drug Fluorothiazinone, 300 Mg Tablets with the Participation of Adult Patients with Chronic Bacterial Cystitis"
- An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
- Antibiotic Prophylaxis and Renal Damage In Congenital Abnormalities of the Kidney and Urinary Tract
- Asymptomatic Bacteriuria in Pregnancy in Low- and Middle-IncomE Countries
- Augmenting Effects of L-DOPS With Carbidopa and Entacapone
- Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease
- Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
Drugs (5)
- Entacapone
- Lonidamine
- Mitoglitazone
- Nitrofurantoin
- Zaprinast